Beneficial Effects of Clarithromycin in Patients With Sepsis
Bibliographic Data
| ID | 5967558 |
|---|---|
| Authors | V Tsarenko, С В Царенко (0000-0002-7065-5331), E P Sovershaeva, Evgeniya Sovershaeva (Lomonosov Moscow State University), L A Davydova (0000-0002-4851-5287) |
| Year | 2013 |
| Volume | 20 |
| Issue | 1 |
| Pages | 54-58 |
| Publication date | 2013-01-15 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Ekologiya Cheloveka (Human Ecology (JOURNAL) |
| Journal identifiers | ISSN: 1728-0869 • E-ISSN: 2949-1444 |
| Publisher | ECO-Vector LLC (PUBLISHER • RU) |
| DOI | 10.17816/humeco17396 |
| OpenAlex | W126731846 |
| Language | EN |
| References cited | 20 |
Nosocomial pneumonia is the most common infection among septic complications with significant impact on patients morbidity and mortality, as well as on the cost of healthcare. Septic complications in patients with severe surgical pathologies are still an urgent problem, and development of modern highly effective methods of prophylaxis is a priority task. Recent studies suggested that clarithromycin may have beneficial effects for patients at risk of certain infections due to their anti-inflammatory and immunomodulatory effects as well as their antimicrobial properties. Addition of clarithromycin to complex therapy of septic complications in intensive care units may have beneficial effects
Antimicrobial · Clarithromycin · Intensive care medicine · Pneumonia · Sepsis · Antibiotic Use and Resistance · Bacterial Identification and Susceptibility Testing · Medicine · Nosocomial Infections in ICU · Internal Medicine
| Highly cited | No |
|---|